Alector, Inc. Common Stock (ALEC) Stock Price

ALECStock

$2.36−8.73%52W

Market Cap$263.51M

P/E—

PEG Ratio—

Div yield—

Beta0.58

ALEC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)4.92%

Price vs S&P 500 (4W)48.26%

VGM Score39.21

Book Value / Share (Quarterly)$0.09

P/TBV (Annual)1.97x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-45.99%

Cash Flow / Share (Quarterly)$-1.56

Price vs S&P 500 (YTD)35.48%

Net Profit Margin (TTM)-680.83%

EPS (TTM)$-1.19

10-Day Avg Trading Volume1.98M

EPS Excl Extra (TTM)$-1.19

Revenue Growth (5Y)-0.05%

EPS (Annual)$-1.39

ROI (Annual)-354.33%

Net Profit Margin (5Y Avg)-209.84%

Cash / Share (Quarterly)$1.86

Revenue Growth QoQ (YoY)-71.53%

ROA (Last FY)-48.74%

Revenue Growth TTM (YoY)-79.15%

EBITD / Share (TTM)$-1.23

ROE (5Y Avg)-146.33%

Operating Margin (TTM)-739.70%

Cash Flow / Share (Annual)$-1.67

P/B Ratio21.89x

P/B Ratio (Quarterly)22.85x

Net Income / Employee (Annual)$-1,387,700

EV / Revenue (TTM)8.69x

ROA (TTM)-40.95%

EV / EBITDA (TTM)3.79x

EPS Incl Extra (Annual)$-1.39

Current Ratio (Annual)3.83x

Quick Ratio (Quarterly)5.04x

3-Month Avg Trading Volume0.88M

52-Week Price Return-8.73%

Revenue / Employee (TTM)$178,800

Tangible BV / Share (Quarterly)$1.93

P/S Ratio (Annual)10.80x

Asset Turnover (Annual)0.07x

52-Week High$3.40

Operating Margin (5Y Avg)-232.60%

EPS Excl Extra (Annual)$-1.39

CapEx CAGR (5Y)-61.74%

Tangible BV CAGR (5Y)53.15%

26-Week Price Return16.16%

Quick Ratio (Annual)3.68x

13-Week Price Return4.07%

Total Debt / Equity (Annual)0.32x

Current Ratio (Quarterly)5.25x

Enterprise Value$160.03M

Revenue / Share Growth (5Y)-5.51%

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-39.32%

Revenue / Employee (Annual)$204,300

Pretax Margin (Annual)-678.36%

Cash / Share (Annual)$2.32

3-Month Return Std Dev101.97%

Net Income / Employee (TTM)$-1,217,400

ROE (Last FY)-466.34%

EPS Basic Excl Extra (Annual)$-1.39

Receivables Turnover (TTM)74.61x

Total Debt / Equity (Quarterly)0.94x

EPS Incl Extra (TTM)$-1.19

Receivables Turnover (Annual)74.66x

ROI (TTM)-240.53%

P/S Ratio (TTM)12.34x

Pretax Margin (5Y Avg)-208.10%

Revenue / Share (Annual)$0.20

Tangible BV / Share (Annual)$2.59

Price vs S&P 500 (52W)-27.04%

Year-to-Date Return47.44%

5-Day Price Return4.07%

EPS Normalized (Annual)$-1.39

ROA (5Y Avg)-23.30%

Net Profit Margin (Annual)-679.16%

Month-to-Date Return52.32%

Cash Flow / Share (TTM)$-1.58

EBITD / Share (Annual)$-1.46

Operating Margin (Annual)-741.30%

LT Debt / Equity (Annual)0.30x

ROI (5Y Avg)-122.63%

LT Debt / Equity (Quarterly)0.80x

EPS Basic Excl Extra (TTM)$-1.19

P/TBV (Quarterly)2.60x

P/B Ratio (Annual)5.56x

Pretax Margin (TTM)-679.92%

Book Value / Share (Annual)$0.28

Price vs S&P 500 (13W)1.28%

Beta0.58x

P/FCF (Annual)0.77x

Revenue / Share (TTM)$0.17

ROE (TTM)-295.17%

52-Week Low$1.09

vGradeC

gGradeF

mGradeC

vgmGradeD

ALEC Earnings Surprise History

Q2 25-0.30est. -0.47

Q3 25-0.34est. -0.41

Q4 25-0.34est. -0.36

Q1 26-0.21est. -0.28

Q2 26-0.21est. -0.23

ALEC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.64

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
ALECAlector, Inc. Common Stock	C	F	C	$2.36
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Alector, Inc. Common Stock

Alector Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegeneration. The company's approach focuses on restoring healthy immune function in the brain to counteract underlying pathologies. Its pipeline includes multiple therapeutic candidates, including AL001, AL002, AL003, and AL101.